• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about James Lanthier

Recent news which mentions James Lanthier

Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials
October 07, 2022
Tickers MSSTF
Tags Markets James Lanthier Psychedelics
From Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers CYBN MSSTF
Tags CYBN James Lanthier Markets
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers MSSTF
Tags major depressive disorder James Lanthier Markets
From Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
September 07, 2022
Tickers MSSTF
Tags intellectual property News Global
From Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
August 31, 2022
Tickers MSSTF
Tags Guidance Cannabis Management
From Benzinga
Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development
June 30, 2022
Tickers MSSTF
Tags psychedelic medicines News Drug Discovery
From Benzinga
Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014
June 22, 2022
Tickers MSSTF
Tags WHO MSSTF Penny Stocks
From Benzinga
Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders
June 10, 2022
Tickers MSSTF
Tags James Lanthier Markets Psychedelics
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap